This document discusses adverse drug reactions (ADRs). It defines ADRs and differentiates them from adverse drug events. It also defines serious adverse events. The document then covers the history of ADR monitoring and reporting, classifications of ADRs by type and category, organ-specific ADRs, and ADR reporting through pharmacovigilance programs. Overall, the document provides an overview of key concepts regarding ADRs, their classification, and monitoring.
An adverse drug reaction (ADR) is an undesirable effect of a drug that occurs at normal dosages during normal use. ADRs can occur after a single dose or prolonged administration and may be beneficial or harmful effects. Major causes of ADRs include drug-drug and drug-food interactions that can alter pharmacokinetics and pharmacodynamics. ADRs are classified as Type A-E with Types A and B being dose-related and idiosyncratic reactions respectively. Over 2 million serious ADRs occur yearly in the US, resulting in 100,000 deaths making ADRs a leading cause of death. Troglitazone was withdrawn from the market in 2000 due to idiosyncratic
This document discusses adverse drug reactions (ADRs). It begins by defining ADRs according to the WHO as any unintended and noxious response to a drug. It then provides a brief history of notable ADR events. The document goes on to classify ADRs based on factors like onset, type of reaction, and severity. It describes each type of reaction with examples. Finally, it discusses other drug-related concepts like side effects, toxicity, dependence, and teratogenicity.
The patient was prescribed ceftriaxone, paracetamol and vitamins for fever. After taking the medications, he developed a rash and macular lesion on his forearm. When the prescribing doctor replaced ceftriaxone with ampicillin, the lesion disappeared. This suggests the patient had an adverse drug reaction to ceftriaxone.
This document discusses adverse drug reactions (ADRs), which are unwanted effects that occur when taking medications. It notes that ADRs are a major cause of hospital admissions and deaths. ADRs are more common in elderly patients due to multiple medications, health issues, and altered drug metabolism. ADRs can be type A, which are dose-dependent and predictable, or type B, which are unpredictable and idiosyncratic. The document emphasizes that carefully selecting drugs and dosages based on a patient's individual characteristics can help reduce the risks of ADRs. Monitoring programs work to detect ADRs and improve drug safety.
Clinical pharmacy involves optimizing medication therapy to improve patient outcomes. It focuses on applying scientific knowledge to medication use and ensuring patients receive the right drug, dose, formulation and regimen. Clinical pharmacists monitor patients, identify medication-related problems, make recommendations to physicians and educate patients. Key activities include consulting, selecting drugs, providing drug information, conducting research and teaching others. Therapeutic drug monitoring involves measuring drug levels to optimize dosing based on a patient's clinical status and pharmacokinetics.
Medication adherence refers to the extent to which a patient follows medical advice regarding prescribed medications. It is important for therapeutic outcomes, especially for chronic illnesses. While many factors can influence adherence, it is difficult to predict. Pharmacists are well-positioned to improve adherence through patient education about their medications, potential side effects, and the importance of adherence. Strategies like simplifying dosing regimens, using medication organizers, and addressing specific barriers can also help. Further research is still needed to better understand and promote adherence.
Drugs can have both beneficial and harmful effects. While drugs save lives and improve health, they can also threaten life. It is important to consider whether the potential benefits of a medication outweigh the risks for a given individual. Adverse drug reactions (ADRs) are a common clinical problem that can have serious consequences for patients, including death. Anyone taking medication can experience an ADR, but some groups are at higher risk, such as the elderly, those taking multiple drugs, and those with multiple medical conditions. Proper diagnosis and management of ADRs is important to prevent further harm.
This document defines and discusses adverse drug reactions (ADRs). It begins by defining an ADR as an unwanted, uncomfortable or dangerous effect from a drug. ADRs can occur due to known side effects or previously unrecognized effects. The document then defines an ADR more specifically as a noxious and unintended response to a medication. It notes that the incidence and severity of ADRs varies depending on patient characteristics like age as well as drug factors like dosage. It describes three main types of ADRs - dose-related, allergic, and idiosyncratic reactions. The document concludes by discussing signs and symptoms of ADRs and providing some examples of mild, moderate, severe and lethal classifications.
An adverse drug reaction (ADR) is an undesirable effect of a drug that occurs at normal dosages during normal use. ADRs can occur after a single dose or prolonged administration and may be beneficial or harmful effects. Major causes of ADRs include drug-drug and drug-food interactions that can alter pharmacokinetics and pharmacodynamics. ADRs are classified as Type A-E with Types A and B being dose-related and idiosyncratic reactions respectively. Over 2 million serious ADRs occur yearly in the US, resulting in 100,000 deaths making ADRs a leading cause of death. Troglitazone was withdrawn from the market in 2000 due to idiosyncratic
This document discusses adverse drug reactions (ADRs). It begins by defining ADRs according to the WHO as any unintended and noxious response to a drug. It then provides a brief history of notable ADR events. The document goes on to classify ADRs based on factors like onset, type of reaction, and severity. It describes each type of reaction with examples. Finally, it discusses other drug-related concepts like side effects, toxicity, dependence, and teratogenicity.
The patient was prescribed ceftriaxone, paracetamol and vitamins for fever. After taking the medications, he developed a rash and macular lesion on his forearm. When the prescribing doctor replaced ceftriaxone with ampicillin, the lesion disappeared. This suggests the patient had an adverse drug reaction to ceftriaxone.
This document discusses adverse drug reactions (ADRs), which are unwanted effects that occur when taking medications. It notes that ADRs are a major cause of hospital admissions and deaths. ADRs are more common in elderly patients due to multiple medications, health issues, and altered drug metabolism. ADRs can be type A, which are dose-dependent and predictable, or type B, which are unpredictable and idiosyncratic. The document emphasizes that carefully selecting drugs and dosages based on a patient's individual characteristics can help reduce the risks of ADRs. Monitoring programs work to detect ADRs and improve drug safety.
Clinical pharmacy involves optimizing medication therapy to improve patient outcomes. It focuses on applying scientific knowledge to medication use and ensuring patients receive the right drug, dose, formulation and regimen. Clinical pharmacists monitor patients, identify medication-related problems, make recommendations to physicians and educate patients. Key activities include consulting, selecting drugs, providing drug information, conducting research and teaching others. Therapeutic drug monitoring involves measuring drug levels to optimize dosing based on a patient's clinical status and pharmacokinetics.
Medication adherence refers to the extent to which a patient follows medical advice regarding prescribed medications. It is important for therapeutic outcomes, especially for chronic illnesses. While many factors can influence adherence, it is difficult to predict. Pharmacists are well-positioned to improve adherence through patient education about their medications, potential side effects, and the importance of adherence. Strategies like simplifying dosing regimens, using medication organizers, and addressing specific barriers can also help. Further research is still needed to better understand and promote adherence.
Drugs can have both beneficial and harmful effects. While drugs save lives and improve health, they can also threaten life. It is important to consider whether the potential benefits of a medication outweigh the risks for a given individual. Adverse drug reactions (ADRs) are a common clinical problem that can have serious consequences for patients, including death. Anyone taking medication can experience an ADR, but some groups are at higher risk, such as the elderly, those taking multiple drugs, and those with multiple medical conditions. Proper diagnosis and management of ADRs is important to prevent further harm.
This document defines and discusses adverse drug reactions (ADRs). It begins by defining an ADR as an unwanted, uncomfortable or dangerous effect from a drug. ADRs can occur due to known side effects or previously unrecognized effects. The document then defines an ADR more specifically as a noxious and unintended response to a medication. It notes that the incidence and severity of ADRs varies depending on patient characteristics like age as well as drug factors like dosage. It describes three main types of ADRs - dose-related, allergic, and idiosyncratic reactions. The document concludes by discussing signs and symptoms of ADRs and providing some examples of mild, moderate, severe and lethal classifications.
ADE
INCIDENCE OF ADR
GREADING OF SEVERITY OF ADR
CLASSIFICATIONS
PHARMACOVIGILANCE
CATAGORIES
CAUSES OF ADR
DRUG INDUCED HEPATIC DYSFUNCTION
DRUG INDUCED ENDOCRINE DYSFUNCTION
DRUG INDUCED PHERIPHERAL NEUROPATHY
MANAGEMENT OF ADR
Hospital pharmacy-Organisation and management
a) Organizational structure-Staff, Infrastructure & work load statistics
b) Management of materials and finance
c) Roles & responsibilities of hospital pharmacist
Role of the pharmacist in medication safety.Subash321
Role of the pharmacist in medication safety. In this you know about the medication safety, medication error & how to prevent medication error. And the role of the pharmacists in medication safety.
This document defines key terms related to adverse drug reactions (ADRs), including what constitutes an ADR, adverse event, and serious ADR. It classifies ADRs into different types (A, B, C, D, E), such as expected/unexpected, allergic, chronic effects, and end of treatment effects. The objectives of ADR monitoring are outlined as detecting the nature and frequency of reactions to assist regulators, educate healthcare professionals, and initiate further studies.
Adverse drug reaction monitoring and reportingTHUSHARA MOHAN
This document discusses types of adverse drug reactions and factors influencing them. It describes types A-E reactions, which include augmented, bizarre, chemical, delayed and end of treatment reactions. Polypharmacy, age, drug characteristics, gender, race and genetic factors can influence susceptibility. Detection methods include pre-marketing studies, post-marketing surveillance, underreporting and communicating reactions. Healthcare professionals should monitor high-risk patients and gather information to assess causality between drugs and adverse events. Underreporting is common due to various barriers but can be addressed through improved reporting systems and education.
This document defines drug interactions and outlines their outcomes, contributing factors, commonly involved drugs, types, mechanisms, and approaches to checking for interactions. It discusses how drug interactions can be beneficial or harmful and result from multiple drug therapy, diseases, prescribers, or noncompliance. The main types are drug-drug, drug-food, and drug-disease interactions, which can occur via pharmaceutical, pharmacokinetic, or pharmacodynamic mechanisms. Factors like absorption, distribution, metabolism, and excretion can be affected. The role of pharmacists in monitoring interactions and educating patients is also covered, as are newer online and mobile tools for checking drug interactions.
Medications are an important tool for preventing illness and disability in older populations, but they can also cause medication-related problems (MRPs). MRPs are undesirable events involving drug therapy that interfere with patient outcomes. Common symptoms of MRPs include changes in speech, falls, confusion, loss of appetite, weakness, incontinence, insomnia, and Parkinson's-like symptoms. Older adults are more at risk for MRPs due to multiple chronic diseases, medications, prescribers, and age-related physiological changes. The presentation provides tips for preventing MRPs such as designating a medication manager, keeping an accurate medication list, consulting providers before starting new medications, and developing routines for administering medications to patients
Introduction to rational use of drugs and role of pharmacist in rational use...Adhin Antony Xavier
This document discusses strategies for promoting rational use of drugs in healthcare systems. It recommends establishing a national drug regulatory authority to oversee drug quality, developing treatment guidelines and an essential drug list. Healthcare professionals should be provided drug information and undergo continuing education on rational prescribing. Generic names should be used and drugs prescribed according to their intended therapeutic uses and appropriate dosages. Quality of drugs must be ensured and irrational self-medication discouraged through public education. Monitoring drug use through indicators can help evaluate prescribing practices and promote rational drug utilization.
The document discusses drug interactions, which occur when two or more drugs react when administered together or in quick succession. There are three types of interactions: drug-drug, drug-food/beverage, and drug-condition. Drug-drug interactions can cause unexpected side effects or make activities like driving dangerous. Interactions are caused by changes to a drug's absorption, distribution, metabolism, or excretion in the body. They can also be due to drugs affecting each other at target sites. Many drug combinations are used deliberately in medicine to produce beneficial effects, but unintended interactions can sometimes lead to serious health issues.
The document discusses adverse drug reactions and their reporting in Nepal. It defines key terms like adverse drug reaction, adverse event and adverse drug effect. It also classifies adverse drug reactions into types A-E based on their mechanism. Common organ specific adverse reactions for liver and kidney are outlined. The national pharmacovigilance program in Nepal and process of adverse drug reaction reporting is described. Treatment for drug induced anaphylaxis focuses on adrenaline administration.
Drug use evaluation (DUE) is a quality improvement process that reviews prescribing patterns to promote appropriate drug use. It involves identifying a drug or therapeutic area, developing criteria and standards, collecting data, evaluating results, providing feedback, and implementing interventions. The process then reevaluates drug use and revises the DUE program as needed. The presented document outlines the 11 steps of a DUE process focusing on monitoring renal function during aminoglycoside therapy.
14ab1t0024 roles and responsibilities of hospital pharmacistRamesh Ganpisetti
Hospital pharmacists play several important roles in ensuring patients receive the most appropriate treatment. They advise patients and medical staff on all aspects of medications, including type, dosage, and administration method based on individual needs. Pharmacists can recommend the best form of medication such as tablets, injections, or inhalers. They are also seen as experts who can advise on safe drug combinations and solutions to specific patient problems. In addition, pharmacists monitor treatment effects to ensure safety, effectiveness, and appropriateness for each user.
Adverse drug reactions (ARs) include all undesirable effects of drug administration, from minor to fatal. ARs can occur promptly or after prolonged use/discontinuation. They are classified into types A-F based on mechanism and timing. Type A reactions are dose-dependent and predictable, while type B reactions only occur in some individuals unpredictably. Types C-E involve long-term, delayed, or ending use effects. Type F are drug interactions. ARs can be minimized by appropriate use, dosing, monitoring, and avoiding interactions but not eliminated.
The document outlines the steps that a poison information specialist should follow to properly handle a poison information query. The specialist must first collect details about the caller and exposure incident. They then assess the urgency of the situation and research treatment options using specialized databases and references. The specialist evaluates the information and provides a tailored response, either verbally or in writing. They may follow up on the case and document the interaction, maintaining confidentiality. The overall process ensures the specialist can safely and effectively assist those exposed to toxic substances.
This document outlines the process and importance of taking a thorough medication history. It discusses that medication history identifies allergies and past medication use, and is the starting point for medication reconciliation and review. The goals are to obtain complete information on all prescription and nonprescription medications, perceived benefits or side effects, and allergies. This helps identify potential medication problems and develop a care plan to improve outcomes. The document then describes how to collect both subjective and objective patient data, from various sources like interviews, records, and providers. It provides a script of questions to ask patients and tips for thorough history taking. The steps of patient selection, preparation, conducting the interview privately, documenting, and following up are also outlined.
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...MerrinJoseph1
Second Pharm D , Community Pharmacy -first chapter,definition of community pharmacy,its scope and the roles and responsibilities of community pharmacist in health care of common people,Dr.Merrin Joseph,Department of pharmacy practice
Drug interaction is defined as the pharmacological activity of one drug is altered by the concomitant use of another drug or by the presence of some other substance.
1.Drug-drug interactions.
2.Drug-food interactions.
3.Chemical-drug interactions.
4.Drug-laboratory test interactions.
5.Drug-disease interactions.
Naranjo
WHO-UMC
Bayesian:
Bayesian
Expert Opinion:
CIOMS
Most commonly used:
Naranjo
WHO-UMC
Naranjo Causality Assessment Scale
Criteria Score
1. Previous conclusive reports on this reaction 0
1. Previous conclusive reports on this reaction +1
2. The adverse event appeared after the suspected drug was administered. +2
3. The adverse reaction improved when the drug was discontinued or a specific antagonist was administered. +1
4. The adverse reaction reappeared when the drug was readministered. +2
5. Alternative causes that could solely have
The document discusses various types of adverse drug reactions (ADRs) and events. It defines an ADR as any noxious change suspected to be caused by a drug taken at normal doses, and an adverse drug event as any untoward occurrence during treatment that may not be causally related. It describes types of ADRs including dose-related type A reactions, unpredictable type B reactions, chronic type C reactions, and withdrawal type E reactions. It also discusses factors influencing ADRs, grading of severity, classifications, mechanisms of hypersensitivity reactions, pharmacovigilance, and prevention of adverse effects.
ADE
INCIDENCE OF ADR
GREADING OF SEVERITY OF ADR
CLASSIFICATIONS
PHARMACOVIGILANCE
CATAGORIES
CAUSES OF ADR
DRUG INDUCED HEPATIC DYSFUNCTION
DRUG INDUCED ENDOCRINE DYSFUNCTION
DRUG INDUCED PHERIPHERAL NEUROPATHY
MANAGEMENT OF ADR
Hospital pharmacy-Organisation and management
a) Organizational structure-Staff, Infrastructure & work load statistics
b) Management of materials and finance
c) Roles & responsibilities of hospital pharmacist
Role of the pharmacist in medication safety.Subash321
Role of the pharmacist in medication safety. In this you know about the medication safety, medication error & how to prevent medication error. And the role of the pharmacists in medication safety.
This document defines key terms related to adverse drug reactions (ADRs), including what constitutes an ADR, adverse event, and serious ADR. It classifies ADRs into different types (A, B, C, D, E), such as expected/unexpected, allergic, chronic effects, and end of treatment effects. The objectives of ADR monitoring are outlined as detecting the nature and frequency of reactions to assist regulators, educate healthcare professionals, and initiate further studies.
Adverse drug reaction monitoring and reportingTHUSHARA MOHAN
This document discusses types of adverse drug reactions and factors influencing them. It describes types A-E reactions, which include augmented, bizarre, chemical, delayed and end of treatment reactions. Polypharmacy, age, drug characteristics, gender, race and genetic factors can influence susceptibility. Detection methods include pre-marketing studies, post-marketing surveillance, underreporting and communicating reactions. Healthcare professionals should monitor high-risk patients and gather information to assess causality between drugs and adverse events. Underreporting is common due to various barriers but can be addressed through improved reporting systems and education.
This document defines drug interactions and outlines their outcomes, contributing factors, commonly involved drugs, types, mechanisms, and approaches to checking for interactions. It discusses how drug interactions can be beneficial or harmful and result from multiple drug therapy, diseases, prescribers, or noncompliance. The main types are drug-drug, drug-food, and drug-disease interactions, which can occur via pharmaceutical, pharmacokinetic, or pharmacodynamic mechanisms. Factors like absorption, distribution, metabolism, and excretion can be affected. The role of pharmacists in monitoring interactions and educating patients is also covered, as are newer online and mobile tools for checking drug interactions.
Medications are an important tool for preventing illness and disability in older populations, but they can also cause medication-related problems (MRPs). MRPs are undesirable events involving drug therapy that interfere with patient outcomes. Common symptoms of MRPs include changes in speech, falls, confusion, loss of appetite, weakness, incontinence, insomnia, and Parkinson's-like symptoms. Older adults are more at risk for MRPs due to multiple chronic diseases, medications, prescribers, and age-related physiological changes. The presentation provides tips for preventing MRPs such as designating a medication manager, keeping an accurate medication list, consulting providers before starting new medications, and developing routines for administering medications to patients
Introduction to rational use of drugs and role of pharmacist in rational use...Adhin Antony Xavier
This document discusses strategies for promoting rational use of drugs in healthcare systems. It recommends establishing a national drug regulatory authority to oversee drug quality, developing treatment guidelines and an essential drug list. Healthcare professionals should be provided drug information and undergo continuing education on rational prescribing. Generic names should be used and drugs prescribed according to their intended therapeutic uses and appropriate dosages. Quality of drugs must be ensured and irrational self-medication discouraged through public education. Monitoring drug use through indicators can help evaluate prescribing practices and promote rational drug utilization.
The document discusses drug interactions, which occur when two or more drugs react when administered together or in quick succession. There are three types of interactions: drug-drug, drug-food/beverage, and drug-condition. Drug-drug interactions can cause unexpected side effects or make activities like driving dangerous. Interactions are caused by changes to a drug's absorption, distribution, metabolism, or excretion in the body. They can also be due to drugs affecting each other at target sites. Many drug combinations are used deliberately in medicine to produce beneficial effects, but unintended interactions can sometimes lead to serious health issues.
The document discusses adverse drug reactions and their reporting in Nepal. It defines key terms like adverse drug reaction, adverse event and adverse drug effect. It also classifies adverse drug reactions into types A-E based on their mechanism. Common organ specific adverse reactions for liver and kidney are outlined. The national pharmacovigilance program in Nepal and process of adverse drug reaction reporting is described. Treatment for drug induced anaphylaxis focuses on adrenaline administration.
Drug use evaluation (DUE) is a quality improvement process that reviews prescribing patterns to promote appropriate drug use. It involves identifying a drug or therapeutic area, developing criteria and standards, collecting data, evaluating results, providing feedback, and implementing interventions. The process then reevaluates drug use and revises the DUE program as needed. The presented document outlines the 11 steps of a DUE process focusing on monitoring renal function during aminoglycoside therapy.
14ab1t0024 roles and responsibilities of hospital pharmacistRamesh Ganpisetti
Hospital pharmacists play several important roles in ensuring patients receive the most appropriate treatment. They advise patients and medical staff on all aspects of medications, including type, dosage, and administration method based on individual needs. Pharmacists can recommend the best form of medication such as tablets, injections, or inhalers. They are also seen as experts who can advise on safe drug combinations and solutions to specific patient problems. In addition, pharmacists monitor treatment effects to ensure safety, effectiveness, and appropriateness for each user.
Adverse drug reactions (ARs) include all undesirable effects of drug administration, from minor to fatal. ARs can occur promptly or after prolonged use/discontinuation. They are classified into types A-F based on mechanism and timing. Type A reactions are dose-dependent and predictable, while type B reactions only occur in some individuals unpredictably. Types C-E involve long-term, delayed, or ending use effects. Type F are drug interactions. ARs can be minimized by appropriate use, dosing, monitoring, and avoiding interactions but not eliminated.
The document outlines the steps that a poison information specialist should follow to properly handle a poison information query. The specialist must first collect details about the caller and exposure incident. They then assess the urgency of the situation and research treatment options using specialized databases and references. The specialist evaluates the information and provides a tailored response, either verbally or in writing. They may follow up on the case and document the interaction, maintaining confidentiality. The overall process ensures the specialist can safely and effectively assist those exposed to toxic substances.
This document outlines the process and importance of taking a thorough medication history. It discusses that medication history identifies allergies and past medication use, and is the starting point for medication reconciliation and review. The goals are to obtain complete information on all prescription and nonprescription medications, perceived benefits or side effects, and allergies. This helps identify potential medication problems and develop a care plan to improve outcomes. The document then describes how to collect both subjective and objective patient data, from various sources like interviews, records, and providers. It provides a script of questions to ask patients and tips for thorough history taking. The steps of patient selection, preparation, conducting the interview privately, documenting, and following up are also outlined.
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...MerrinJoseph1
Second Pharm D , Community Pharmacy -first chapter,definition of community pharmacy,its scope and the roles and responsibilities of community pharmacist in health care of common people,Dr.Merrin Joseph,Department of pharmacy practice
Drug interaction is defined as the pharmacological activity of one drug is altered by the concomitant use of another drug or by the presence of some other substance.
1.Drug-drug interactions.
2.Drug-food interactions.
3.Chemical-drug interactions.
4.Drug-laboratory test interactions.
5.Drug-disease interactions.
Naranjo
WHO-UMC
Bayesian:
Bayesian
Expert Opinion:
CIOMS
Most commonly used:
Naranjo
WHO-UMC
Naranjo Causality Assessment Scale
Criteria Score
1. Previous conclusive reports on this reaction 0
1. Previous conclusive reports on this reaction +1
2. The adverse event appeared after the suspected drug was administered. +2
3. The adverse reaction improved when the drug was discontinued or a specific antagonist was administered. +1
4. The adverse reaction reappeared when the drug was readministered. +2
5. Alternative causes that could solely have
The document discusses various types of adverse drug reactions (ADRs) and events. It defines an ADR as any noxious change suspected to be caused by a drug taken at normal doses, and an adverse drug event as any untoward occurrence during treatment that may not be causally related. It describes types of ADRs including dose-related type A reactions, unpredictable type B reactions, chronic type C reactions, and withdrawal type E reactions. It also discusses factors influencing ADRs, grading of severity, classifications, mechanisms of hypersensitivity reactions, pharmacovigilance, and prevention of adverse effects.
This document discusses adverse drug reactions (ADRs). It defines ADRs according to the WHO and UMC as unintended, harmful reactions that occur at normal drug doses. It discusses the history of ADR monitoring and important events like the Thalidomide tragedy. It also defines various ADR terminology and categorizes ADRs into types A-F based on factors like dose, time, and withdrawal. Finally, it discusses pharmacovigilance - the science of detecting, assessing and preventing ADRs - and methods used like spontaneous reporting and intensive monitoring.
This document provides information on adverse drug reactions (ADRs), including:
1. It defines ADRs and differentiates them from adverse drug events, and outlines some common causes of events that are excluded from being considered ADRs.
2. It describes various types and classifications of ADRs, including by intensity/severity, outcome, mechanism of production, and pharmacoepidemiological criteria.
3. It discusses methods of pharmacovigilance for detecting ADRs and standards for determining the imputability or likelihood that a reaction was caused by a drug.
This document discusses adverse drug reactions (ADRs), their classification and prevention. It defines ADRs as noxious changes caused by drugs taken at normal doses. ADRs are classified as type A (predictable, dose-dependent) or type B (unpredictable, immune-mediated). It also describes various types of ADRs including augmented, bizarre, continuous, delayed, ending use and failure of efficacy reactions. The document emphasizes the importance of pharmacovigilance in detecting, understanding and preventing ADRs through activities like monitoring, data analysis and issuing safety guidelines. It concludes with examples of preventing ADRs through rational drug use and always considering ADRs when new symptoms arise during treatment.
For all III YouTube Live Video lecture series of this topic click:
https://youtube.com/playlist?list=PLBVbJ9HCa1BbWpd06N6RcV2q0K3JT29Wv
- For More Such Learning You Can Subscribe to My YouTube Channel.
https://www.youtube.com/channel/UC5o-WkzmDJaF7udyAP2jtgw/featured?sub_confirmation=1
Facebook Page: https://www.facebook.com/asacademylearningforever
Website Blog: https://itasacademy.blogspot.com/
This document defines adverse drug reactions and discusses their epidemiology, classification, detection, and monitoring. It provides definitions of adverse drug reactions from WHO and other organizations. It describes the incidence, costs, and preventability of ADRs. It classifies ADRs into types A-F based on mechanisms and discusses methods to determine causality, including the Naranjo algorithm. It outlines the pharmacovigilance system in India including monitoring centers coordinated by AIIMS.
This document discusses adverse drug reactions (ADRs), including definitions, classifications, mechanisms, risk factors, and prevention strategies. It defines ADRs as noxious changes suspected to be caused by a drug. ADRs can be classified as type A (predictable, dose-related) or type B (unpredictable, immune-mediated). Risk factors for ADRs include polypharmacy, older age, multiple illnesses, and malnutrition. Prevention strategies include appropriate dosing, monitoring for new symptoms, and considering drug interactions and patient history. The document also covers topics like drug dependence, teratogenicity, and the role of pharmacovigilance in monitoring ADRs.
Adverse Drug Reaction by Firoz Rosid.pptxFirozRosid1
Adverse reaction of any drug is a major concerning issue in many countries. A medicine may act as poison without proper dosing as well as management. Sometimes, adverse drug reaction is life threatening. About 10% of diseased people are dying due to adverse reaction of drug. They even don't know why medicine is not being effective them well. So, to get proper medication, knowledge about adverse drug reaction is a must.
Drugs can have both beneficial and harmful effects. While drugs save lives and improve health, they can also threaten life. Whether the potential benefits of a medication outweigh the risks depends on the individual taking it. Adverse drug reactions (ADRs) are a common clinical problem that can have serious consequences for patients, from mere inconvenience to death. Anyone taking medication can experience an ADR, but some groups are at higher risk, such as the elderly, those taking multiple drugs, and those with multiple medical conditions. ADRs should be considered if new symptoms appear after starting or increasing a drug dose and disappear after stopping the drug. The most common causes of ADRs are antibiotics, anticancer drugs, cardiovascular drugs,
This document provides an overview of adverse drug reactions (ADRs). It defines what constitutes an ADR and different types of ADRs such as Type A, B, C, D and E reactions. It notes that ADRs are common, increasing healthcare costs and hospital stays. Causes of ADRs include patient factors, drug factors and prescriber factors. Historical examples of drug-induced harms are provided. The importance of pharmacovigilance programs for post-marketing drug safety monitoring is highlighted.
This document defines and describes various types of adverse drug reactions and events. It discusses pharmacovigilance, which is the science related to detecting, assessing, understanding, and preventing adverse drug effects. The document categorizes adverse drug effects into side effects, allergy reactions, toxicity, intolerance, idiosyncrasy, photosensitivity, dependence, withdrawal reactions, teratogenicity, mutagenicity, carcinogenicity, and drug-induced diseases. It provides examples and treatments for different types of reactions. Pharmacovigilance helps educate doctors about adverse drug reactions and regulates safe drug use.
This document discusses adverse drug reactions and pharmacovigilance. It defines adverse drug reactions as noxious changes suspected to be caused by a drug. Adverse drug reactions are classified based on their timing (immediate, delayed), severity (minor to lethal), predictability (type A - dose-dependent and type B - unpredictable), and other characteristics. The document also discusses preventing adverse reactions through appropriate drug use and monitoring patients for new symptoms after starting treatment. Pharmacovigilance aims to detect, understand and prevent adverse drug reactions through postmarketing surveillance.
This document discusses adverse drug reactions (ADRs). It defines ADRs as noxious changes suspected to be caused by a drug. It notes the incidence of ADRs is higher in populations like the elderly, children, and pregnant women. ADRs can develop immediately or after prolonged medication use, and are classified based on their severity from minor to lethal. The document also categorizes ADRs and discusses types like augmented, bizarre, chronic, delayed, and ending drug use. It covers topics such as pharmacovigilance, preventing ADRs, drug interactions, and classifications including side effects, toxicity, intolerance, and idiosyncrasy.
This document discusses adverse drug reactions (ADRs). It defines ADRs as noxious changes suspected to be caused by a drug. It notes the incidence is higher in populations like the elderly, children, and immunosuppressed individuals. ADRs can develop immediately or after prolonged medication use, and are graded based on their severity. ADRs are broadly classified as Type A (predictable) or Type B (unpredictable). It also discusses concepts like idiosyncrasy, allergy, dependence, withdrawal, teratogenicity, and pharmacovigilance monitoring of ADRs.
Adverse drug reactions (ADRs) are any noxious, unintended changes in the body which occur at normal dosages of a drug. ADRs can be caused by drugs' intended pharmacological effects or unpredictable reactions. They are a major issue due to polypharmacy, the elderly, children, and immunosuppressed patients being more susceptible. ADRs are classified based on timing (immediate, delayed), severity (minor to lethal), predictability (type A-pharmacological, type B-immunological), and chronicity. Preventing ADRs involves appropriate drug use, monitoring for reactions, and being aware patients' medical histories and laboratory values can increase risks.
Pharmacovigilance is the science related to detecting, assessing, understanding, and preventing adverse effects from drugs. It plays an important role in rational drug use and safety assessment. Adverse drug reactions are unintended effects that occur at normal drug doses, while adverse drug events may or may not be causally related to treatment. Adverse effects can be categorized as side effects, interactions, toxic effects, idiosyncrasies, allergies, withdrawal reactions, teratogenicity, mutagenicity, carcinogenicity, and drug-induced diseases. Minimizing inappropriate use, using correct doses, considering patient variables and history, checking for interactions, and monitoring can help reduce adverse drug reactions.
The document discusses various types of adverse drug reactions (ADRs), including:
1. Predictable (Type A) reactions which are dose-dependent and based on the drug's pharmacological properties. These occur in normal patients and account for 80% of ADRs.
2. Unpredictable (Type B) reactions which are idiosyncratic, dose-independent, and related to the patient's peculiarities or immune response. These are less common but more serious.
3. Factors that influence the risk of ADRs like polypharmacy, use in elderly patients, prolonged drug therapy, and individual patient variability. Close monitoring is important to prevent adverse outcomes from medication.
This document discusses various types of adverse drug effects. It defines adverse effect as any undesirable consequence of drug administration, including noxious and even fatal effects. Adverse effects are classified as predictable or unpredictable. Predictable effects are based on the pharmacological properties of the drug and include side effects and consequences of overdose or withdrawal. Unpredictable effects are based on patient peculiarities and include allergies and idiosyncrasies. The document then examines specific types of adverse effects in more detail such as side effects, secondary effects, toxicity, intolerance, idiosyncrasy, allergy, dependence, withdrawal reactions, teratogenicity, carcinogenicity and drug-induced diseases.
This document provides an overview of various research study designs, including:
- Descriptive studies like case reports, case series, ecological studies, and cross-sectional studies.
- Analytical studies like cohort studies and case-control studies.
- Experimental studies like clinical trials, which can be randomized controlled trials.
It discusses key aspects of designing research like formulating research questions and hypotheses, objectives, biases, and techniques to reduce biases like randomization and blinding.
This document discusses evaluation methods for cardiotonic drugs, which are used to treat congestive heart failure. It describes both in vivo and in vitro methods. For in vivo methods, it outlines several animal models used, including rat models (such as coronary ligation and aortic banding), dog models (like chronic rapid pacing and volume overload), and rabbit models. These allow testing of drugs on intact animals and evaluation of factors like cardiac output and neurohormonal levels. In vitro methods described involve isolated tissue preparations and cell cultures to assess effects on a mechanistic level.
Dr. Sneha Dange will present on the pharmacotherapy of glaucoma. The presentation will cover the anatomy of the eye relevant to glaucoma, the goals of glaucoma treatment, and an overview of current pharmacotherapy options including beta blockers, alpha agonists, prostaglandin analogues, cholinergic agonists, carbonic anhydrase inhibitors, and hyperosmotic agents. Recent advances discussed will include antioxidants, forskolin, and Ginkgo biloba as complementary treatments.
Pharmacotherapy of Neurodegenrative diseases DrSnehaDange
This document provides an overview of various neurodegenerative diseases and their pharmacotherapy. It discusses the mechanism of neuronal cell death including protein misfolding and aggregation, excitotoxicity, and apoptosis. Several neurodegenerative diseases are then examined in more detail, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, and others. For each disease, the document discusses aspects such as pathology, genetics, clinical features, and pharmacotherapy options.
Pharmacotherapy of Cardiac arrhythmiasDrSnehaDange
This document provides an overview of pharmacotherapy for cardiac arrhythmias. It discusses the normal conduction pathway in the heart and mechanisms of arrhythmogenesis. Cardiac arrhythmias are classified and characteristics of different types are described including extrasystoles, supraventricular tachycardia, atrial flutter, atrial fibrillation, ventricular tachycardia and ventricular fibrillation. Antiarrhythmic drugs are classified according to the Vaughan Williams system with details provided on mechanisms and examples for Class IA, IB, IC, II, III and IV drugs.
This document provides an overview of dermatopharmacology and summarizes key topics including skin structure, principles of topical drug application, antimicrobial agents, antifungal agents, antiviral agents, immunosuppressants, and recent advances. It discusses the structure of the epidermis and dermis, formulations for topical drug delivery, potency classifications of topical corticosteroids, mechanisms and indications for various antimicrobial, antifungal and antiviral agents.
The document discusses various antiviral drugs used to treat viral infections. It begins by describing viruses and their replication cycles. It then classifies antiviral drugs based on their mechanisms of action and discusses individual drugs used to treat herpes viruses, influenza viruses, hepatitis viruses, cytomegalovirus, and more. Key drugs mentioned include acyclovir, valacyclovir, famciclovir for herpes, oseltamivir and zanamivir for influenza, and ganciclovir and valganciclovir for cytomegalovirus. The document provides details on the mechanisms, uses, and side effects of many commonly used antiviral medications.
This document provides an overview of pharmacotherapy for pain management. It discusses the physiology of pain including the ascending and descending pain pathways. It describes the different types of pain and classifications. For pharmacotherapy, it explains the WHO three-step ladder approach starting with non-opioid analgesics like NSAIDs, then weak opioids, and finally strong opioids. It provides details of commonly used non-opioid and opioid analgesics, their dosages, properties and side effects. The document emphasizes a multidisciplinary approach for pain management including pharmacotherapy, physiotherapy, and cognitive behavioral therapy.
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
MBC Support Group for Black Women – Insights in Genetic Testing.pdfbkling
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
2. OVERVIEW
Important Definitions
History
Types of ADR
Organ specific ADR
ADR reporting (pharmacovigilance)
Summary
7/16/2021
2
Adverse drug reaction
3. Adevrse Drug Reaction (ADR)
“An appreciably harmful or unpleasant
reaction, resulting from an intervention
related to the use of a medicinal product,
which predicts hazard from future
administration and warrants prevention or
specific treatment, or alteration of the
dosage regimen, or withdrawal of the
product.”
7/16/2021
3
Adverse drug reaction
4. Adverse Drug Events
“Any untoward medical occurrence that may
present during treatment with a medicine but
does not have causal relationship with the
treatment.“
7/16/2021
4
Adverse drug reaction
5. Serious Adverse Event
7/16/2021
Adverse drug reaction
5
Any untoward medical occurrence,
that at any dose;
Results in death
Requires hospitalization or prolongation of existing
hospitalization
Results in persistent significant disability or
incapacity
Requires intervention to prevent permanent injury
6. History
o From the earliest times, pharmaceutical formulations
have been recognized as being potentially dangerous.
o Public and professional concern about these matters
first arose in the late 19th century.
o In 1922, there was an enquiry into JAUNDICE
associated with the use of SALVARSAN, an organic
arsenical used in the treatment of Syphillis.
7/16/2021
6
Adverse drug reaction
7. In 1937 in USA,
107 people died from taking
an Elixir Of Sulfanilamide
that contained the Solvent
Di-ethylene Glycol
This led to establishment of FOOD AND DRUG
ADMINISTRATION (FDA), which was given the task of
enquiring into the safety of new drugs before allowing them to
be marketed
7/16/2021
7 Adverse drug reaction
8. In 1961, it was reported in West Germany that there
was an outbreak of PHOCOMELIA (hypoplastic and
aplastic limb deformities) in the new born babies.
7/16/2021
8
Adverse drug reaction
9. The Thalidomide Incident led to development of a
much more sophisticated approach to preclinical
testing & clinical evaluation of drugs before
marketing, & greatly increased awareness of
adverse effect of drugs and methods of detecting
them.
7/16/2021
9
Adverse drug reaction
11. Rawlins and Thompson’s classification
Type Mnemonic Example
A Augmented Diarrohea due to antibiotics
B Bizzare Hypersensitivity due to penicillin
C Chronic Steroid decrease HPA axis
D Delayed Teratogenicity, carcinogenesis
E End of use Precipitation of MI by β blocker
withdrawl
F Failure OCP failure
11
12. Type A (Augmented)
More common,dose dependent
Augmented normal response
Predictable ,Low mortality
d/t pharmacological action of drug
Rx- dose adjustment
Eg. side effects, toxic effects, secondary effects
7/16/2021
12
Adverse drug reaction
13. Type B (Bizzare)
Less common, Dose independent
Abnormal/bizzare response, unpredictable
Genetic/immunological
High mortality, d/t pecularities of patient
Rx-withdrawal of drug
e.g. Allergy,idiosyncrasy
7/16/2021
13
Adverse drug reaction
14. Type C (Chronic)
Reactions due to prolonged use of drugs
Dose and time dependent
eg. Cushing syndrom due to corticosteroids.
Colonic dysfunction after prolonged use
laxatives.
7/16/2021
14
Adverse drug reaction
15. Type D (Delayed)
Occuring after years of treatment
Time dependent
e.g: Secondary cancers in patients treated
for Hodgkin’s disease.
Teratogenic effects.
7/16/2021
15
Adverse drug reaction
16. Type E (End of treatment)
Occur when drug is suddenly discontinued
e.g: Withdrawal seizures - phenytoin.
Rebound hypertention - propranolol.
7/16/2021
16
Adverse drug reaction
17. Type F (failure of drug)
Occurs when administration of drug does not
produce therapeutic effect
e.g: Genetic variability
Drug interactions
7/16/2021
17
Adverse drug reaction
18. Grades of ADR
Mild No need of Rx, antidote or Hospitalization
Moderate Requires drug change specific
Rx, hospitalization
Severe Potentially life threatening;
permanent damage, and prolonged hospitalization.
Lethal Directly or indirectly leads to
death
7/16/2021
18
Adverse drug reaction
20. 1.Side Effects
“Unwanted and unavoidable effects of a drug at
therapeutic doses”
Eg. Extension of therapeutic effect
Atropine - dry mouth
As distinctly different effect
Promethazine – Sedation.
Side effect exploited for therapeutic use
Codeine – Diarrhoea
7/16/2021
20
Adverse drug reaction
Categories of ADR (Contd..)
21. Categories of ADR (Contd..)
2.Secondary effects
“Indirect consequence of Primary action of
the drug.”
Eg. Tetracycline - Superinfection
Corticosteroids - Activation of
latent Tuberculosis
7/16/2021
21
Adverse drug reaction
22. 3.Toxic Effects
“Excessive pharmacological action of a drug due to
over dosage or prolonged use”
E.g. - Functional alteration : Atropine - delirium
- Drug induced tissue damage : PCM – Hepatic
necrosis
- Extension of therapeutic effect : Barbiturates-
Coma
- Another action : Morphine – Respiratory failure
7/16/2021
22
Adverse drug reaction
Categories of ADR (Contd..)
23. 4.Intolerance
“Appearance of characteristic toxic effects
of a drug at therapeutic doses”
Eg. Triflupromazine (single dose) – Muscular
dystonia
Chloroquine (single dose) - Vomiting
7/16/2021
23
Adverse drug reaction
Categories of ADR (Contd..)
24. 5.Idiosyncrasy
Unusual response to a drug due to genetic
abnormality.
Drug interacts with some unique feature of
individual, not found in majority subjects, &
produces the uncharacteristic reaction.
Eg. Chloramphenicol - aplastic anaemia,,
Succinylcholine - Malignant hyperthermia
7/16/2021
24
Adverse drug reaction
Categories of ADR (Contd..)
25. 6.Drug allergy
Acquired, altered reaction of the body to drug.
Immunologically mediated reaction.
occur even with much smaller doses
Also called Drug hypersensitivity
Not genetic, not occur in all
Occurs on re-exposure
7/16/2021
25
Adverse drug reaction
Categories of ADR (Contd..)
26. Type of reaction Time
before
clinical
sign
Characteristics Example
Anaphylactic
(Immediate IgE-
mediated
anaphylaxis)
< 30 min
IgE binds to must cell or basophil,causes
degranulation of must cell & basophil&
release of reactive subs. histamine
Penicillin
anaphylaxis
Cytotoxic
(Antibody-
Dependent
Cellular
Cytotoxicity
5 –
12 hr
Antigen cause formation of IgG or IgM
antibodies to bind that .
Drug forms an antigenic complex with the
surface of the cell and combination with
antibody activate complement system
causing cell destruction.
Thrombocytopenia:
Quinidine
SLE:Hydralazine or
Procainamide.
Immune complex
mediated
8-10days antigen antibody form complexes that
causes inflammation
Steven-Johnson Syn
Serum Sickness
Cell mediated
allergy(delayed
type)
2-3 days Antigen specific receptors develop on T-
lymphocytes. Subsequent administration
leads to local or tissue allergy.
Contact dermatitis
28. 8.Drug dependence and addiction
Drugs capable of altering mood and feelings are liable
for repetitive use to derive euphoria, withdrawal
from reality, social adjustment, etc.
Psychological dependence: Individual believes that
optimal state of well being is achieved only through
the actions of the drug.
E.g. Opioids, Cocaine.
7/16/2021
28
Adverse drug reaction
Categories of ADR (Contd..)
29. Physical dependence:
Altered physiological state produced by repeated
administration of a drug which necessitates the
continued presence of the drug to maintain
physiological equilibrium.
E.g. Opioids, Barbiturates, Alcohol, Benzodiazepines
7/16/2021
29
Adverse drug reaction
Categories of ADR (Contd..)
30. 9.Mutagenicity and carcinogenicity
Capacity of a drug to cause genetic defects and
cancer respectively.
Chemical carcinogenesis generally takes several (10-
40) years to develop.
Unpredictable
E.g.,
Estrogen- Endometrial carcinoma.
OCP- Ca cervix, breast Ca
7/16/2021
30
Adverse drug reaction
Categories of ADR (Contd..)
31. 10.Teratogenicity
Capacity of drug causing foetal abnormalities when
given to pregnant woman
US FDA graded documentation of risk for causing
birth defects into five categories ABCDX
Eg: Phenytoin – cleft palate
Valproate – Spina bifida
7/16/2021
31
Adverse drug reaction
Categories of ADR (Contd..)
33. 11.Tachyphylaxis
When responseiveness diminishes after repeated
and frequent administration of a drug, the response
is said to be subject to tachyphylaxis.
Eg. Tyramine can cause depletion of all NE stores if we
use it repeatedly at short interval, resulting in
tachyphylaxis.
7/16/2021
33
Adverse drug reaction
Categories of ADR (Contd..)
38. How to prevent ADR
7/16/2021
Adverse drug reaction
38
Rational use of drugs
Proper drug history and drug allergy history
To check possiblity of drug interaction
Assessment of risk benefit ratio
Advice pt, not to take drugs without advice
40. ADR reporting
Pharmacovigilace
“The science and activities relating to
detection, assessment, understanding &
prevention of adverse effects or any other
drug related problem.“
7/16/2021
40
Adverse drug reaction
41. Aims and Objectives
7/16/2021
Adverse drug reaction
41
Contribute to assessment of benefit,harm,effectiveness
& risk of medicines,encouraging their safe,rational &more
effective use
To improve public health & safety in relation to use of
medicine
Promote understanding,education & clinical training in
pharmacovigilance & its effective communication to public
42. Summary
ADR are ‘’adverse effects’’ which has causal relationship
with drugs
Types of ADR – type A, type B, type C,type D,type E
type F
Severity – Mild, Moderate, Severe, Lethal
Others – side effects, secondary effects, toxic effects,
allergy, idiosyncracy, intolerence, photosensitivity, drug
dependence, mutagenicity,carcinogenicity,teratogenicity,
tachyphylaxis
ADR reporting(Pharmacovigilance) plays an important role
in drug evolution & safty of public health
7/16/2021
42
Adverse drug reaction
43. References
Goodman and Gilman's -13th The Pharmacological
basis of Therapeutics
Principles of pharmacology-HL Sharma & KK Sharma
ADR: Definition,diagnosis & management
The LANCET,Vol 356,2000.
7/16/2021
43
Adverse drug reaction